367 related articles for article (PubMed ID: 18312579)
21. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
Sloat BR; Cui Z
Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
[TBL] [Abstract][Full Text] [Related]
22. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
[TBL] [Abstract][Full Text] [Related]
24. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
25. A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.
Hu DL; Cui JC; Omoe K; Sashinami H; Yokomizo Y; Shinagawa K; Nakane A
Infect Immun; 2005 Jan; 73(1):174-80. PubMed ID: 15618152
[TBL] [Abstract][Full Text] [Related]
26. [Evidence of enterotoxins and toxic shock syndrome toxin (TSST-1) in strains of Staphylococcus aureus isolated from various biological materials].
Simkovicová M; Hanzen J; Milosovic P; Lisálová M; Jakubovská M
Epidemiol Mikrobiol Imunol; 2002 Aug; 51(3):102-6. PubMed ID: 12184187
[TBL] [Abstract][Full Text] [Related]
27. Occurrence of toxic shock syndrome toxin-1 producing Staphylococcus aureus and the anti TSST-1 serostatus of hospital personnel in Nigeria.
Olusanya O; Naidu AS
East Afr Med J; 1991 Jul; 68(7):507-14. PubMed ID: 1756702
[TBL] [Abstract][Full Text] [Related]
28. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
[TBL] [Abstract][Full Text] [Related]
29. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
Yang X; Walters N; Robison A; Trunkle T; Pascual DW
Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
Park JY; Kim JS; Woo H
Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of recombinant SEA-TSST fusion toxoid for protection against superantigen induced toxicity in mouse model.
Reddy PN; Paul S; Sripathy MH; Batra HV
Toxicon; 2015 Sep; 103():106-13. PubMed ID: 26091873
[TBL] [Abstract][Full Text] [Related]
32. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
[TBL] [Abstract][Full Text] [Related]
33. IFN-gamma plays a detrimental role in murine defense against nasal colonization of Staphylococcus aureus.
Satorres SE; Alcaráz LE; Cargnelutti E; Di Genaro MS
Immunol Lett; 2009 Apr; 123(2):185-8. PubMed ID: 19428568
[TBL] [Abstract][Full Text] [Related]
34. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock.
Rajagopalan G; Smart MK; Murali N; Patel R; David CS
J Reprod Immunol; 2007 Feb; 73(1):51-9. PubMed ID: 17070600
[TBL] [Abstract][Full Text] [Related]
35. Mucosal genetic immunization against four adhesins protects against Staphylococcus aureus-induced mastitis in mice.
Castagliuolo I; Piccinini R; Beggiao E; Palù G; Mengoli C; Ditadi F; Vicenzoni G; Zecconi A
Vaccine; 2006 May; 24(20):4393-402. PubMed ID: 16580097
[TBL] [Abstract][Full Text] [Related]
36. Antibodies against superantigenic exotoxins produced by Staphylococcus aureus in sera from mothers and their infants' cord blood.
Takahashi N; Hattori M; Miwa K; Nishida H
Am J Perinatol; 2006 Oct; 23(7):413-9. PubMed ID: 17004199
[TBL] [Abstract][Full Text] [Related]
37. Early diagnosis of staphylococcal toxic shock syndrome by detection of the TSST-1 Vbeta signature in peripheral blood of a 12-year-old boy.
Ferry T; Thomas D; Bouchut JC; Lina G; Vasselon-Raina M; Dauwalder O; Gillet Y; Vandenesch F; Floret D; Etienne J
Pediatr Infect Dis J; 2008 Mar; 27(3):274-7. PubMed ID: 18277923
[TBL] [Abstract][Full Text] [Related]
38. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
Uppalapati SR; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
[TBL] [Abstract][Full Text] [Related]
39. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
Asano K; Narita K; Hirose S; Nakane A
Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
[TBL] [Abstract][Full Text] [Related]
40. Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1.
Kalyan S; Chow AW
J Infect Dis; 2004 May; 189(10):1892-6. PubMed ID: 15122526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
